Cervarix, manufactured by GlaxoSmithKline, was approved Friday for prevention of cervical cancer and pre-cancerous lesions caused by human papillomavirus (HPV) types 16 and 18. The vaccine is ...

Vaccine efficacy of 100% was observed against HPV-16/18-related cervical intraepithelial ... integrated safety analyses show that Cervarix has a favorable safety profile in diverse populations ...

There's a second vaccine in the works: Cervarix, from GlaxoSmithKline. Cervarix targets two HPV strains, HPV-16 and HPV-18. GSK says it plans to seek FDA approval for Cervarix by the end of the year.

Cervarix: population analyzed in this table were seronegative to HPV-16 and -18, and PCR DNA negative to 14 high-risk HPV types at study entry. Gardasil: population analyzed in this table were ...

Gardasil 9 is the only HPV vaccine used in the U.S., and it’s also one of the only vaccines on the market that actually prevents cancer. That’s because HPV is behind nearly all cervical cancer cases ...

have both been awarded a significant portion of the UNICEF HPV vaccine tender in order to provide the vaccinations. GSK is to provide a supply of Cervarix® (Human Papillomavirus vaccine [Types 16 ...

Picture this: It’s circa 2012 and I’m 13 years old, sitting awkwardly in my doctor’s office for my yearly physical, learning about the HPV vaccine. My doctor has just explained that the ...

HPV vaccines are safe and protect against many types of cancer including cervical, throat, and anal. Common HPV vaccine side effects should subside in 2 days and include dizziness, nausea ...